Bernd Melchers
Director/Board Member chez INTELGENX TECHNOLOGIES CORP.
Fortune : 21 120 $ au 31/03/2024
Profil
Bernd Josef Melchers is currently a Director at Intelgenx Corp.
and an Independent Director at IntelGenx Technologies Corp.
He previously worked as the Managing Director at 3M Dyneon Holding GmbH and as the Chief Financial Officer at 3M Dyneon Group.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/01/2024 | 120 000 ( 0,07% ) | 21 120 $ | 31/03/2024 |
Postes actifs de Bernd Melchers
| Sociétés | Poste | Début |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Director/Board Member | 16/04/2009 |
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Director/Board Member | - |
Anciens postes connus de Bernd Melchers
| Sociétés | Poste | Fin |
|---|---|---|
| 3M Dyneon Holding GmbH | President | - |
| 3M Dyneon Group | Director of Finance/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
| 3M Dyneon Holding GmbH | |
| 3M Dyneon Group |
